Ceribell

About Ceribell

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Founded

2014

CEO

Dr. Xingjuan Chao, PhD

Employees

327

Headquarters

Sunnyvale, California, United States of America

Fiscal year end

12-31

Website

ceribell.com

Company profile

Exchange

US

Symbol

CBLL

Market-cap rank

#3313

Listing date

2024-10-11

Market cap

906.87M

Float cap

625.20M

Shares out

38.38M

Float shares

26.46M

Sectors & themes

Browse all sectors & themes